| A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets N Deng, LK Goh, H Wang, K Das, J Tao, IB Tan, S Zhang, M Lee, J Wu, ... Gut 61 (5), 673-684, 2012 | 713 | 2012 |
| Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial C Cainap, S Qin, WT Huang, IJ Chung, H Pan, Y Cheng, M Kudo, ... Journal of Clinical Oncology 33 (2), 172, 2015 | 651 | 2015 |
| Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms RE Tay, EK Richardson, HC Toh Cancer gene therapy 28 (1), 5-17, 2021 | 628 | 2021 |
| Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma M Garnelo, A Tan, Z Her, J Yeong, CJ Lim, J Chen, KH Lim, A Weber, ... Gut 66 (2), 342-351, 2017 | 420 | 2017 |
| Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy IB Tan, T Ivanova, KH Lim, CW Ong, N Deng, J Lee, SH Tan, J Wu, ... Gastroenterology 141 (2), 476-485. e11, 2011 | 411 | 2011 |
| Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma V Chew, J Chen, D Lee, E Loh, J Lee, KH Lim, A Weber, K Slankamenac, ... Gut 61 (3), 427-438, 2012 | 375 | 2012 |
| Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients V Chew, C Tow, M Teo, HL Wong, J Chan, A Gehring, M Loh, A Bolze, ... Journal of hepatology 52 (3), 370-379, 2010 | 299 | 2010 |
| Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation … TR Spitzer, S McAfee, R Sackstein, C Colby, HC Toh, P Multani, ... Biology of Blood and Marrow Transplantation 6 (3), 309-320, 2000 | 292 | 2000 |
| Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinoma WK Chia, M Teo, WW Wang, B Lee, SF Ang, WM Tai, CL Chee, J Ng, ... Molecular Therapy 22 (1), 132-139, 2014 | 284 | 2014 |
| Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis IAW Ho, HC Toh, WH Ng, YL Teo, CM Guo, KM Hui, PYP Lam Stem cells 31 (1), 146-155, 2013 | 280 | 2013 |
| Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma CJ Lim, YH Lee, L Pan, L Lai, C Chua, M Wasser, TKH Lim, J Yeong, ... Gut 68 (5), 916-927, 2019 | 273 | 2019 |
| Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 … AT Deyrup, VK Lee, CE Hill, W Cheuk, HC Toh, S Kesavan, EW Chan, ... The American journal of surgical pathology 30 (1), 75-82, 2006 | 256 | 2006 |
| Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma AX Zhu, AR Abbas, MR de Galarreta, Y Guan, S Lu, H Koeppen, W Zhang, ... Nature medicine 28 (8), 1599-1611, 2022 | 237 | 2022 |
| Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses V Chew, L Lai, L Pan, CJ Lim, J Li, R Ong, C Chua, JY Leong, KH Lim, ... Proceedings of the National Academy of Sciences 114 (29), E5900-E5909, 2017 | 206 | 2017 |
| Immune microenvironment in tumor progression: characteristics and challenges for therapy V Chew, HC Toh, JP Abastado Journal of oncology 2012 (1), 608406, 2012 | 205 | 2012 |
| Loss of BCAA catabolism during carcinogenesis enhances mTORC1 activity and promotes tumor development and progression RE Ericksen, SL Lim, E McDonnell, WH Shuen, M Vadiveloo, PJ White, ... Cell metabolism 29 (5), 1151-1165. e6, 2019 | 187 | 2019 |
| Targeting dendritic cells to enhance DNA vaccine potency Z You, X Huang, J Hester, HC Toh, SY Chen Cancer research 61 (9), 3704-3711, 2001 | 181 | 2001 |
| Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy Y Zhao, TWH Shuen, TB Toh, XY Chan, M Liu, SY Tan, Y Fan, H Yang, ... Gut 67 (10), 1845-1854, 2018 | 166 | 2018 |
| RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma H Huynh, KH Pierce Chow, KC Soo, HC Toh, SP Choo, KF Foo, D Poon, ... Journal of cellular and molecular medicine 13 (7), 1371-1380, 2009 | 165 | 2009 |
| Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma CH Hsu, TS Yang, C Hsu, HC Toh, RJ Epstein, LT Hsiao, PJ Chen, ZZ Lin, ... British Journal of Cancer 102 (6), 981-986, 2010 | 162 | 2010 |
